Losmapimod oral tablet

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Facioscapulohumeral Muscular Dystrophy (FSHD)

Drug Information

Target Indication

Facioscapulohumeral Muscular Dystrophy (FSHD)

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

FULC

Fulcrum Therapeutics, Inc.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts